I need a name of company or a lab sells the AAV-IGF-I and where?

It appears that AAV-IGF1 is a long way from being available to the
general public. It has not yet been approved by the FDA. The biotech
company Ceregene is developing AAV-IGF1 under the name Cere-130:

"Ceregene, Inc., San Diego, California

This effort is part of several studies required for development and
FDA- approval of adeno-associated viral vector ?IGF1 (AAV -IGF1) or
Cere-130."

http://www.alsa.org/research/grant.cfm?id=503&CFID=626810&CFTOKEN=68925638

"The ALS Association (ALSA) today announced funding support of a new
pre-clinical study at Ceregene, Inc. to help move viral delivery of
insulin-like growth factor 1 (IGF-1) closer to the clinic for patients
with amyotrophic lateral sclerosis (ALS).

This effort is part of several studies required for development and
FDA approval of CERE-130. CERE-130 is a novel gene therapy product
that involves the delivery of IGF-1 through an adeno-associated viral
(AAV) vector. In partnership with The Robert Packard Center for ALS
Research at Johns Hopkins and Project A.L.S., these efforts are vital
to moving viral delivery of IGF-1 into clinical trials."

http://www.rideforlife.com/archives/001107.html

Contact info for Ceregene may be found here:

http://ceregene.com/f-contact.html